Gary Zieziula
Directeur/Membre du Conseil chez INNOVENT BIOLOGICS, INC.
Fortune : 23 851 $ au 30/04/2024
Postes actifs de Gary Zieziula
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| INNOVENT BIOLOGICS, INC. | Directeur/Membre du Conseil | 31/05/2022 | - |
| Independent Dir/Board Member | 31/05/2022 | - |
Historique de carrière de Gary Zieziula
Anciens postes connus de Gary Zieziula
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | 01/01/2014 | - |
| President | - | 01/09/2018 | |
| AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | 28/04/2010 | 04/11/2011 |
| MERCK & CO., INC. | Sales & Marketing | - | - |
| BRISTOL-MYERS SQUIBB COMPANY | Sales & Marketing | - | - |
Formation de Gary Zieziula
| Canisius College | Masters Business Admin |
| State University of New York at Buffalo | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
| Îles Cayman | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Sales & Marketing | 2 |
| Masters Business Admin | 1 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| MERCK & CO., INC. | Health Technology |
| INNOVENT BIOLOGICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
- Bourse
- Insiders
- Gary Zieziula
- Expérience